Genetic Polymorphisms and Tissue Expression of Interleukin-22 Associated with Risk and Therapeutic Response of Gastric Mucosa-associated Lymphoid Tissue Lymphoma

Overview

Journal Blood Cancer J

Date 2014 Oct 11

PMID 25303370

Citations 14

Authors

F Liao

Y-C Hsu

S-H Kuo

Y-C Yang

J-P Chen

P-N Hsu

C-W Lin

L-T Chen

A-L Cheng

C S J Fann

J-T Lin

M-S Wu

Affiliations

Soon will be listed here.

Abstract

Chronic Helicobacter pylori-stimulated immune reactions determine the pathogenesis of gastric mucosa-associated lymphoid tissue (MALT) lymphoma. We aimed to explore the genetic predisposition to this lymphoma and its clinical implication. A total of 68 patients and 140 unrelated controls were genotyped for 84 single-nucleotide polymorphisms in genes encoding cytokines, chemokines and related receptors that play important roles in T cell-mediated gastrointestinal immunity. Five genotypes in IL-22, namely CC at rs1179246, CC at rs2227485, AA at rs4913428, AA at rs1026788 and TT at rs7314777, were associated with disease susceptibility. The former four genotypes resided in the same linkage disequilibrium block (r(2)=0.99) that conferred an approximately threefold higher risk. In vitro experiments demonstrated that co-culturing peripheral mononuclear cells or CD4(+) T cells with H. pylori stimulated the secretion of interleukin-22 (IL-22), and that IL-22 induced the expression of antimicrobial proteins, RegIIIα and lipocalin-2, in gastric epithelial cells. Furthermore, patients with gastric tissue expressing IL-22 were more likely to respond to H. pylori eradication (14/22 vs 4/19, P<0.006). We conclude that susceptibility of gastric MALT lymphoma is influenced by genetic polymorphisms in IL-22, the product of which is involved in mucosal immunity against H. pylori and associated with tumor response to H. pylori eradication.

Citing Articles

Cooperative participation of CagA and NFATc1 in the pathogenesis of antibiotics-responsive gastric MALT lymphoma.

Tsai H, Yeh K, Lin C, Wu M, Liou J, Hsu P Cancer Cell Int. 2024; 24(1):383.

PMID: 39558403 PMC: 11575159. DOI: 10.1186/s12935-024-03552-6.

The role of IL-22 in cancer.

Hunzeker Z, Zhao L, Kim A, Parker J, Zhu Z, Xiao H Med Oncol. 2024; 41(10):240.

PMID: 39231878 DOI: 10.1007/s12032-024-02481-8.

An overview of the correlation between IPI and prognosis in primary breast lymphoma.

Feng K, Zhao S, Shang Q, Liu J, Yang C, Ren F Am J Cancer Res. 2023; 13(1):245-260.

PMID: 36777506 PMC: 9906079.

Role of Gastric Microorganisms Other than in the Development and Treatment of Gastric Diseases.

Duan X, Chen P, Xu X, Han M, Li J Biomed Res Int. 2022; 2022:6263423.

PMID: 35321071 PMC: 8938066. DOI: 10.1155/2022/6263423.

Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment.

Biernat M, Wrobel T Int J Mol Sci. 2021; 22(14).

PMID: 34298992 PMC: 8305669. DOI: 10.3390/ijms22147372.

References

Houghton J, Fox J, Wang T . Gastric cancer: laboratory bench to clinic. J Gastroenterol Hepatol. 2002; 17(4):495-502. DOI: 10.1046/j.1440-1746.2002.02770.x. View

Zhang G, Chen X, Chan L, Zhang M, Zhu B, Wang L . An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese. Sci Rep. 2012; 1:20. PMC: 3216508. DOI: 10.1038/srep00020. View

Hendrik Niess J, Brand S, Xiubin Gu , Landsman L, Jung S, McCormick B . CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005; 307(5707):254-8. DOI: 10.1126/science.1102901. View

Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F . Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol. 2009; 10(8):857-63. DOI: 10.1038/ni.1767. View

Kotenko S, Izotova L, Mirochnitchenko O, Esterova E, Dickensheets H, Donnelly R . Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem. 2000; 276(4):2725-32. DOI: 10.1074/jbc.M007837200. View

Marchesi F, Martin A, Thirunarayanan N, Devany E, Mayer L, Grisotto M . CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol. 2009; 2(6):486-94. DOI: 10.1038/mi.2009.113. View

Hellmig S, Vollenberg S, Goebeler-Kolve M, Fischbach W, Hampe J, Folsch U . IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection. Blood. 2004; 104(9):2994-5. DOI: 10.1182/blood-2004-05-1792. View

DElios M, Andersen L . Helicobacter pylori inflammation, immunity, and vaccines. Helicobacter. 2007; 12 Suppl 1:15-9. DOI: 10.1111/j.1523-5378.2007.00530.x. View

Sommer F, Faller G, Konturek P, Kirchner T, Hahn E, Zeus J . Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun. 1998; 66(11):5543-6. PMC: 108696. DOI: 10.1128/IAI.66.11.5543-5546.1998. View

10.

Ito T, Carson 4th W, Cavassani K, Connett J, Kunkel S . CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res. 2011; 317(5):613-9. PMC: 3063449. DOI: 10.1016/j.yexcr.2010.12.018. View

11.

Gelebart P, Zak Z, Dien-Bard J, Anand M, Lai R . Interleukin 22 signaling promotes cell growth in mantle cell lymphoma. Transl Oncol. 2011; 4(1):9-19. PMC: 3026902. DOI: 10.1593/tlo.10172. View

12.

Zheng Y, Valdez P, Danilenko D, Hu Y, Sa S, Gong Q . Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008; 14(3):282-9. DOI: 10.1038/nm1720. View

13.

Zucca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E . Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med. 1998; 338(12):804-10. DOI: 10.1056/NEJM199803193381205. View

14.

Hellmig S, Bartscht T, Fischbach W, Folsch U, Schreiber S . Interleukin-10 (-819 C/T) and TNF-A (-308 G/A) as risk factors for H. pylori-associated gastric MALT-lymphoma. Dig Dis Sci. 2008; 53(7):2007-8. DOI: 10.1007/s10620-008-0231-0. View

15.

Wotherspoon A, Ortiz-Hidalgo C, Falzon M, Isaacson P . Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991; 338(8776):1175-6. DOI: 10.1016/0140-6736(91)92035-z. View

16.

Suarez F, Lortholary O, Hermine O, Lecuit M . Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006; 107(8):3034-44. DOI: 10.1182/blood-2005-09-3679. View

17.

Jaffe E, Banks P, Nathwani B, Said J, Swerdlow S . Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. Mod Pathol. 2003; 17(1):131-5. DOI: 10.1038/sj.modpathol.3800028. View

18.

Cogliatti S, Schmid U, Schumacher U, Eckert F, Hansmann M, Hedderich J . Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology. 1991; 101(5):1159-70. DOI: 10.1016/0016-5085(91)90063-q. View

19.

Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa J, Renauld J . Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 2002; 277(37):33676-82. DOI: 10.1074/jbc.M204204200. View

20.

Dumoutier L, Van Roost E, Colau D, Renauld J . Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci U S A. 2000; 97(18):10144-9. PMC: 27764. DOI: 10.1073/pnas.170291697. View